![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Preinitiation |
Unique ID issued by UMIN | UMIN000017439 |
Receipt No. | R000020218 |
Scientific Title | Laser thermotherapy for radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy |
Date of disclosure of the study information | 2015/08/01 |
Last modified on | 2016/05/07 |
Basic information | ||
Public title | Laser thermotherapy for radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy
|
|
Acronym | Laser thermotherapy for radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy
|
|
Scientific Title | Laser thermotherapy for radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy
|
|
Scientific Title:Acronym | Laser thermotherapy for radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy
|
|
Region |
|
Condition | |||
Condition | Patients with radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy | ||
Classification by specialty |
|
||
Classification by malignancy | Malignancy | ||
Genomic information | NO |
Objectives | |
Narrative objectives1 | To evaluate clinical safety and performance testing of the newly
developed laser thermotherapy equipment for patients with radioresistant cervical cancer after radiotherapy |
Basic objectives2 | Safety |
Basic objectives -Others | |
Trial characteristics_1 | Exploratory |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Assessment of safety
-Measured by incidence of adverse events before, in and after treatment and until 6 months after the treatment. |
Key secondary outcomes |
Base | |
Study type | Interventional |
Study design | |
Basic design | Single arm |
Randomization | Non-randomized |
Randomization unit | |
Blinding | Open -no one is blinded |
Control | Uncontrolled |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | |||
No. of arms | 1 | ||
Purpose of intervention | Treatment | ||
Type of intervention |
|
||
Interventions/Control_1 | The newly developed laser thermotherapy
equipment 1. Thermotherapy is one time a week. 2. Heating time is from 40 to 50 minutes at 43-45 degrees. 3. Thermotherapy is done 5 or 6 times. |
||
Interventions/Control_2 | |||
Interventions/Control_3 | |||
Interventions/Control_4 | |||
Interventions/Control_5 | |||
Interventions/Control_6 | |||
Interventions/Control_7 | |||
Interventions/Control_8 | |||
Interventions/Control_9 | |||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Female | |||
Key inclusion criteria | (1)A patient with superficial lesion and a little tumor amount.
(2)A patient with no recurrent lesion except for recurrence of uterine cervix in pelvis, or a patients with an expected survival of more than 6 months after this treatment. (3)A patient without distant metastasis. (4))A patient with difficulty of additional radiation therapy. (5)A patient with difficulty of operation or with refusal of operation. (6)A patient without indication of chemotherapy or with refusal of chemotherapy. (7)A patient who has been diagnosed with recurrent or residual cancer of the uterine cervix based on histology (biopsy). (8)A patient who has squamous cell carcinoma, adenosquamous cell carcinoma, or adenocarcinoma is limited. (9)A patient with an expected survival of more than 6 months. (10)A female patient aged 20 years or older at the time of enrollment and a patient who has provided written informed consent to partcipate in this study. |
|||
Key exclusion criteria | (1)A patient who cannot be inserted this equipment through the vagina and can be hard to attain to a lesion.
(2)A patient with collagen disease. (3)A patient with active double cancer. (4)A patient whom the investigator considers to be ineligible as a subject. |
|||
Target sample size | 5 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Nagoya University Graduate School of Medicine | ||||||
Division name | Therapeutic Radiology | ||||||
Zip code | |||||||
Address | 65 Tsurumai-cho, Showa-ku, Nagoya | ||||||
TEL | 052-744-2544 | ||||||
itoh@med.nagoya-u.ac.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Nagoya University Hospital | ||||||
Division name | Dept. of Radiology | ||||||
Zip code | |||||||
Address | 65 Tsurumai-cho, Showa-ku, Nagoya | ||||||
TEL | 052-744-2328 | ||||||
Homepage URL | |||||||
itoh@med.nagoya-u.ac.jp |
Sponsor | |
Institute | Nagoya University Hospital |
Institute | |
Department |
Funding Source | |
Organization | None |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | |
Address | |
Tel | |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Preinitiation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date | |||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020218 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |